Sign in to view content

Higher Order OCT Feature Assessment of the Impact of Fluid Dynamics on Visual Acuity in Neovascular AMD in a Phase III Clinical Trial: The Importance of Outer Retinal Integrity

Justis P. Ehlers, MD, FASRS

Video
Published 2022

Related

Anti-VEGF treatment switch in DME and nAMD: a comparison of aflibercept versus ranibizumab after a single-dose switch
Estephania Feria, MD
On Demand Cases, Courses, and Papers
2019
Episode 157: March Retinal Physician Review with Dr. Shriji Patel including discussion of complement inhibition for AMD, faricimab, brolucizimab, and prefilled syringes for injectable medications
Jayanth Sridhar, MD
Member Podcasts
2018
Ziv-aflibercept Efficacy in Better Regulating Neovascular AMD (ZEBRA) Trial
Kapil G. Kapoor, MD
On Demand Cases, Courses, and Papers
2019

Category: AMD-Neovascular

See more